Shu-ichi Kanazashi, President and CEO of UMN Pharma, made a special-session presentation at the 10th International Bio Technology Exhibition & Conference, Bio Expo Japan, held from 29 June to 1 July, 2011, at the Tokyo International Exhibition Center (Tokyo Big Sight). His lecture was entitled:‘Development of New Recombinant Influenza Vaccines Manufactured by Insect Cell Culture.’
